HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results Life Science Investing
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License Biotech Investing
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Life Science Investing
Rain Enhancement Technologies Reports Consistent Snowpack Enhancement Across Three-Month Winter Operations in Utah Life Science Investing
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 , a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease Life Science Investing
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference Life Science Investing
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates Life Science Investing
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs Life Science Investing
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
